نتائج البحث - Laurence Sanhès

تنقيح النتائج
  1. 1
    Survival Response to B-Cell Receptor Ligation Is Restricted to Progressive Chronic Lymphocytic Leukemia Cells Irrespective of Zap70 Expression

    Survival Response to B-Cell Receptor Ligation Is Restricted to Progressive Chronic Lymphocytic Leukemia Cells Irrespective of Zap70 Expression حسب Pierre‐Antoine Deglesne, Nathalie Chevallier, Rémi Letestu, Fanny Baran‐Marszak, Taoufik Beitar, Célia Salanoubat, Laurence Sanhès, J Nataf, Claudine Roger, Nadine Varin‐Blank, Florence Ajchenbaum‐Cymbalista

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)

    Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the beh... حسب Sylvain Thépot, Raphaël Itzykson, Valérie Seegers, Emmanuel Raffoux, Bruno Quesnel, Yasmine Chaït, L. Sorin, François Dreyfus, Thomas Cluzeau, Jacques Delaunay, Laurence Sanhès, Virginie Éclache, Caroline Dartigeas, Pascal Turlure, Stéphanie Harel, Célia Salanoubat, Jean‐Jacques Kiladjian, Pierre Fenaux, Lionel Adès

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Good Syndrome: An Adult-Onset Immunodeficiency Remarkable for Its High Incidence of Invasive Infections and Autoimmune Complications

    Good Syndrome: An Adult-Onset Immunodeficiency Remarkable for Its High Incidence of Invasive Infections and Autoimmune Complications حسب Marion Malphettes, Laurence Gérard, Lionel Galicier, David Boutboul, Bouchra Asli, Raphaël Szalat, Antoinette Perlat, A. Masseau, N. Schleinitz, G. Le Guenno, Jean‐François Viallard, Bernard Bonnotte, M.F. Thiercelin-Legrand, Laurence Sanhès, Raphaël Borie, Sophie Georgin‐Lavialle, Claire Fieschi, Éric Oksenhendler

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study

    Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study حسب Morgane Cheminant, Coralie Derrieux, Aurore Touzart, Stephanie L. Schmit, A Grenier, A. Trinquand, Marie‐Hélène Delfau‐Larue, Ludovic Lhermitte, Catherine Thiéblemont, Vincent Ribrag, S. Chèze, Laurence Sanhès, F. Jardin, F. Lefrère, Richard Delarue, Eva Hoster, M. Dreyling, Vahid Asnafi, Olivier Hermine, Elizabeth Macintyre

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with <scp>l</scp>‐asparaginase: The <scp>GRAALL</scp> experience

    Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with <scp>l</scp>‐asparaginase: The <scp>GRAA... حسب Marie‐Anne Couturier, Françoise Huguet, Patrice Chevallier, Felipe Suárez, Xavier Thomas, Martine Escoffre‐Barbe, Victoria Cacheux, Jean‐Michel Pignon, Caroline Bonmati, Laurence Sanhès, Pierre Bories, Étienne Daguindau, Véronique Dorvaux, Oumédaly Reman, Jamilé Frayfer, Corentin Orvain, Véronique Lhéritier, Norbert Ifrah, Hervé Dombret, Mathilde Hunault, Aline Schmidt

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial

    Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial حسب Thorsten Braun, Raphaël Itzykson, Aline Renneville, Benoît de Renzis, François Dreyfus, Kamel Laribi, Krimo Bouabdallah, Norbert Vey, Andréa Toma, Christian Récher, Bruno Royer, Bertrand Joly, Anne Vekhoff, Ingrid Lafon, Laurence Sanhès, Guillaume Meurice, Cédric Oréar, Claude Preudhomme, Claude Gardin, Lionel Adès, Michaëla Fontenay, Pierre Fenaux, Nathalie Droin, Éric Solary

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    A randomized phase II trial of azacitidine +/- epoetin- in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents

    A randomized phase II trial of azacitidine +/- epoetin- in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents حسب Sylvain Thépot, Raouf Ben Abdelali, Sylvie Chevret, Aline Renneville, Odile Beyne‐Rauzy, Thomas Prébet, S. Park, Aspasia Stamatoullas, A. Guerci-Bresler, S. Chèze, G. Tertian, Bachra Choufi, Laurence Legros, Jean Bastié, J. Delaunay, M.P. Chaury, Laurence Sanhès, Eric Wattel, François Dreyfus, Norbert Vey, Fatiha Chermat, Claude Preudhomme, Pierre Fenaux, Claude Gardin

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure

    A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure حسب Marie Sébert, Aline Renneville, Cécile Bally, Pierre Péterlin, Odile Beyne‐Rauzy, Laurence Legros, Marie-Pierre Gourin, Laurence Sanhès, Eric Wattel, Emmanuel Gyan, Sophie Park, Aspasia Stamatoullas, Anne Banos, Kamel Laribi, Simone Jueliger, Luke Bevan, Fatiha Chermat, Rosa Sapena, Olivier Nibourel, Cendrine Chaffaut, Sylvie Chevret, Claude Preudhomme, Lionel Adès, Pierre Fenaux

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Real‐World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated Before the Era of Anti‐<scp>CD38</scp> Antibodies: The <scp>EMMY</scp> Cohort From 2017 to 2020

    Real‐World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated Before the Era of Anti‐<scp>CD38</scp> Antibodies: The <scp>EMMY</scp> Cohort From 2017 to 2020 حسب Laure Vincent, Olivier Decaux, Aurore Perrot, Bruno Royer, Thomas Chalopin, Arthur Bobin, Margaret Macro, D. Caillot, Lionel Karlin, Caroline Jacquet, Cécile Sonntag, Mohamad Mohty, Laurent Frenzel, Arnaud Jaccard, Morten Salomo, Laurence Sanhès, Driss Chaoui, Philippe Moreau, Ronan Garlantézec, Nathalie Texier, Chanaz Louni, Zakaria Maarouf, Hervé Avet‐Loiseau, Cyrille Hulin, Karim Belhadj Merzoug

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    A <scp>P</scp>hase 2 study of <scp>L</scp>‐asparaginase encapsulated in erythrocytes in elderly patients with <scp>P</scp>hiladelphia chromosome negative acute lymphoblastic leukemia: The <scp>GRASPALL/GRAALL‐SA</scp>2‐2008 study

    A <scp>P</scp>hase 2 study of <scp>L</scp>‐asparaginase encapsulated in erythrocytes in elderly patients with <scp>P</scp>hiladelphia chromosome negative acute lymphoblastic leukem... حسب Mathilde Hunault, Thibaut Leguay, Françoise Huguet, Stéphane Leprêtre, Éric Deconinck, Mario Ojeda‐Uribe, Caroline Bonmati, Martine Escoffre‐Barbe, Pierre Bories, Chantal Himberlin, Patrice Chevallier, Philippe Rousselot, Oumédaly Reman, Marie‐Laure Boulland, Séverine Lissandre, Pascal Turlure, Didier Bouscary, Laurence Sanhès, O. Legrand, Mårina Lafage‐Pochitaloff, Marie C. Béné, D Liens, Yann Godfrin, Norbert Ifrah, Hervé Dombret

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Nilotinib (Tasigna®) and Low Intensity Chemotherapy for First-Line Treatment of Elderly Patients with BCR-ABL1-Positive Acute Lymphoblastic Leukemia: Final Results of a Prospective Multicenter Trial (EWALL-PH02)

    Nilotinib (Tasigna®) and Low Intensity Chemotherapy for First-Line Treatment of Elderly Patients with BCR-ABL1-Positive Acute Lymphoblastic Leukemia: Final Results of a Prospective... حسب Oliver G. Ottmann, Roman Pfeifer, Jean‐Michel Cayuela, Karsten Spiekermann, Wolfram Jung, Joachim Beck, Emmanuel Raffoux, Pascal Turlure, Chantal Himberlin, Françoise Huguet, Andreas Viardot, Knut Wendelin, Albrecht Reichle, Sébastien Maury, Laurence Sanhès, Françoise Isnard, Jean‐Yves Cahn, Stéphane Leprêtre, Patrice Chevallier, Martine Escoffre‐Barbe, Josep‐María Ribera, Dieter Hoelzer, Nicola Goekbuget, Hervé Dombret, Philippe Rousselot

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort study

    Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort study حسب Hege Kristin Gravdahl Garelius, Timothy Bagguley, Adele M. Taylor, Pierre Fenaux, David Bowen, Argiris Symeonidis, Moshe Mittelmann, Reinhard Stauder, Jaroslav Čermák, Guillermo Sanz, Saskia Langemeijer, Luca Malcovati, Ulrich Germing, Laurence Sanhès, Maud D’Aveni, Dominic Culligan, Ιoannis Kotsianidis, Karin A. Koinig, Corine van Marrewijk, Simon Crouch, Theo deWitte, Alexandra Smith, Eva Hellström‐Lindberg

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Validation of the revised international prognostic scoring system (<scp>IPSS</scp>‐R) in patients with lower‐risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet <scp>MDS</scp> (<scp>EUMDS</scp>) registry

    Validation of the revised international prognostic scoring system (<scp>IPSS</scp>‐R) in patients with lower‐risk myelodysplastic syndromes: a report from the prospective European... حسب Louise de Swart, Alex Smith, W. Thomas Johnston, Detlef Haase, Jackie Droste, Pierre Fenaux, Argiris Symeonidis, Guillermo Sanz, Eva Hellström‐Lindberg, Jaroslav Čermák, Ulrich Germing, Reinhard Stauder, Otilia Georgescu, Marius MacKenzie, Luca Malcovati, Mette Skov Holm, António Almeida, Krzysztof Mądry, Borhane Slama, Agnès Guerci‐Bresler, Laurence Sanhès, Odile Beyne‐Rauzy, Elisa Luño, David Bowen, Théo de Witte

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Results From a Prospective, Open-Label, Phase II Trial of Bendamustine in Refractory or Relapsed T-Cell Lymphomas: The BENTLY Trial

    Results From a Prospective, Open-Label, Phase II Trial of Bendamustine in Refractory or Relapsed T-Cell Lymphomas: The BENTLY Trial حسب Gandhi Damaj, Rémy Gressin, Krimo Bouabdallah, Guillaume Cartron, Bachra Choufi, Emmanuel Gyan, Anne Banos, Arnaud Jaccard, Sophie Park, Olivier Tournilhac, Jean-Marc Schiano-de Collela, Laurent Voillat, Bertrand Joly, Steven Le Gouill, Alain Saad, Pascale Cony‐Makhoul, Jean‐Pierre Vilque, Laurence Sanhès, Aline Schmidt, Michaël Bubenheim, Roch Houot, Momar Diouf, Jean‐Pierre Marolleau, Marie C. Béné, Antoine Martin, T. Lamy

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    del(17p) without <i>TP53</i> mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma

    del(17p) without <i>TP53</i> mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma حسب Jill Corre, Aurore Perrot, Denis Caillot, Karim Belhadj, Cyrille Hulin, Xavier Leleu, Mohamad Mohty, Thierry Façon, Laure Buisson, Laura Do Souto, Romain Lannes, Stéphanie Dufrechou, Naïs Prade, Frédérique Orsini‐Piocelle, Laurent Voillat, Arnaud Jaccard, Lionel Karlin, Margaret Macro, Sabine Bréchignac, Mamoun Dib, Laurence Sanhès, Jean Fontan, Lauriane Clément-Filliatre, Jean‐Pierre Marolleau, Stéphane Minvielle, Philippe Moreau, Hervé Avet‐Loiseau

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor

    Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor حسب Anaïs Schavgoulidze, Alexis Talbot, Aurore Perrot, Titouan Cazaubiel, Xavier Leleu, Salomon Manier, Laure Buisson, Sabrina Mahéo, Laura Do Souto Ferreira, Luka Pavageau, Cyrille Hulin, Jean‐Pierre Marolleau, Laurent Voillat, Karim Belhadj, Marion Divoux, Borhane Slama, Sabine Bréchignac, Margaret Macro, Anne-Marie Stoppa, Laurence Sanhès, Frédérique Orsini-Piocelle, Jean Fontan, Marie‐Lorraine Chrétien, Hélène Demarquette, Mohamad Mohty, Hervé Avet‐Loiseau, Jill Corre

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    High total metabolic tumor volume at baseline predicts survival independent of response to therapy

    High total metabolic tumor volume at baseline predicts survival independent of response to therapy حسب Laëtitia Vercellino, Anne‐Ségolène Cottereau, Olivier Casasnovas, Hervé Tilly, Pierre Feugier, Loïc Chartier, Christophe Fruchart, Louise Roulin, Lucie Obéric, Gian Matteo Pica, Vincent Ribrag, Julie Abraham, Marc A. Simon, Hugo González, Réda Bouabdallah, Olivier Fitoussi, Catherine Sebban, Armando López‐Guillermo, Laurence Sanhès, Franck Morschhauser, Judith Trotman, Bernadette Corront, Bachra Choufi, Sylvia Snauwaert, Pascal Godmer, Josette Brière, Gilles Salles, Philippe Gaulard, Michel Meignan, Catherine Thiéblemont

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Treatment of Older Patients with Mantle-Cell Lymphoma

    Treatment of Older Patients with Mantle-Cell Lymphoma حسب Hanneke C. Kluin‐Nelemans, Eva Hoster, Olivier Hermine, Jan Walewski, Marek Trněný, Carsten Geisler, Stephan Stilgenbauer, Catherine Thiéblemont, Ursula Vehling‐Kaiser, Jeanette K. Doorduijn, Bertrand Coiffier, Roswitha Forstpointner, Hervé Tilly, Lothar Kanz, Pierre Feugier, Michał Szymczyk, Michael Hallek, Stephan Kremers, G. Lepeu, Laurence Sanhès, Josée M. Zijlstra, Réda Bouabdallah, Pieternella J. Lugtenburg, Margaret Macro, Michael Pfreundschuh, Vít Procházka, Francesco Di Raimondo, Vincent Ribrag, M. Uppenkamp, Marc André, W. Klapper, W. Hiddemann, Michael Unterhalt, Martin Dreyling

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    A randomized phase 3 trial of auto vs. allo transplantation as part of first-line therapy in poor-risk peripheral T-NHL

    A randomized phase 3 trial of auto vs. allo transplantation as part of first-line therapy in poor-risk peripheral T-NHL حسب Norbert Schmitz, Lorenz Truemper, Krimo Bouabdallah, Marita Ziepert, Mathieu Leclerc, Guillaume Cartron, Arnaud Jaccard, Peter Reimer, Eva Wagner-Drouet, Martin Wilhelm, Laurence Sanhès, Thierry Lamy, Laurence de Leval, Andreas Rosenwald, Murielle Roussel, Frank Kroschinsky, Walter Lindemann, Peter Dreger, Andreas Viardot, Nöel Milpied, Christian Gisselbrecht, Gerald Wulf, Emmanuel Gyan, Philippe Gaulard, Jacques‐Olivier Bay, Bertram Glaß, Viola Poeschel, Gandhi Damaj, David Sibon, Alain Delmer, Karin Bilger, Anne Banos, Mathias Haenel, Martin Dreyling, Bernd Metzner, Ulrich Keller, Friederike Braulke, Birte Friedrichs, Maike Nickelsen, Bettina Altmann, Olivier Tournilhac

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion

    Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion حسب Andréa Toma, Olivier Kosmider, Sylvie Chevret, J. Delaunay, Aspasia Stamatoullas, Christian Rosé, Odile Beyne‐Rauzy, A. Baños, A. Guerci-Bresler, Stefan Wickenhauser, Denis Caillot, Kamel Laribi, Benoît de Renzis, Dominique Bordessoule, Claude Gardin, Bohrane Slama, Laurence Sanhès, Bérengère Gruson, Pascale Cony‐Makhoul, Bachra Chouffi, Célia Salanoubat, Riad Benramdane, Laurence Legros, Eric Wattel, G. Tertian, Krimo Bouabdallah, François Guilhot, A.-L. Taksin, S. Chèze, Karim Maloum, S. Nimuboma, Carole Soussain, F Isnard, Emmanuel Gyan, Robert G. Petit, Julie Lejeune, Veronique Sardnal, Aline Renneville, Claude Preudhomme, Michaëla Fontenay, Pierre Fenaux, François Dreyfus

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: